Diaphragmatic dysfunction is an underdiagnosed cause of dyspnea and should always be considered in the differential diagnosis of unexplained dyspnea. [7] [8] [9] Dysfunction of the diaphragm ranges from a partial loss of the ability to generate pressure (weakness) to a complete loss of diaphragmatic function (paralysis). 6, 10 Diaphragmatic weakness or paralysis can involve either one or both hemidiaphragms and may be seen in the context of metabolic or inflammatory disorders, after trauma or surgery, during mechanical ventilation, and with mediastinal masses, myopathies, neuropathies, or diseases that cause lung hyperinflation. 3, 4, 6, [11] [12] [13] [14] Patients with unilateral diaphragmatic paralysis are usually asymptomatic but may have dyspnea on exertion and limited ability to exercise (Table 1) . 5, [14] [15] [16] Occasionally, patients with unilateral diaphragmatic paralysis report dyspnea when they are supine. Coexisting conditions such as obesity, weakness of other muscle groups, or underlying heart and lung disease (e.g., chronic obstructive pulmonary disease) may worsen dyspnea in patients with unilateral diaphragmatic paralysis, especially when they are supine. 17 If patients have no symptoms, unilateral diaphragmatic paralysis may be discovered as an incidental radiographic finding of an elevated hemidiaphragm.
Patients with bilateral diaphragmatic paralysis or severe diaphragmatic weakness are more likely to have symptoms and may present with unexplained dyspnea or recurrent respiratory failure. They can have considerable dyspnea at rest, when supine, with exertion, or when immersed in water above their waist. 4, 8 They often need to use a recliner for sleep and to avoid swimming or activities that require bending. 3 A history of chest surgery, manipulation of the cervical spine, neck injury, a slowly pro-gressive neuromuscular disease, or acute neck or shoulder pain should be sought in patients with either unilateral or bilateral diaphragmatic paralysis. 4 Patients with bilateral diaphragmatic paralysis are at an increased risk for sleep fragmentation and hypoventilation during sleep. 18, 19 Consequently, initial symptoms may include fatigue, hypersomnia, depression, morning headaches, and frequent nocturnal awakenings. Other complications of bilateral diaphragmatic paralysis include subsegmental atelectasis and infections of the lower respiratory tract.
On examination, tachypnea and use of accessory muscles may be noted during quiet breathing. 4 The use of accessory muscles can be recognized by palpating the neck; the examiner can sense contraction of the sternocleidomastoid muscles during inspiratory efforts. Decreased diaphragmatic excursion may be detected by percussion of the lower rib cage at end expiration and end inspiration. The most characteristic physical sign of diaphragmatic dysfunction is abdominal paradox, which is the paradoxical inward motion of the abdomen as the rib cage expands during inspiration (Fig. 2) . 4, 20 This disordered breathing pattern results from compensatory use of the accessory inspiratory muscles of the rib cage and neck. 15, 21 When these muscles contract and lower pleural pressure, the weakened or flaccid diaphragm moves in a cephalad direction and the abdominal wall moves inward. This paradoxical breathing pattern is most easily seen with the patient in the supine position. Abdominal paradox is typically observed when the maximum transdiaphragmatic pressure that the patient can generate against a closed airway is less than 30 cm of water 10 ; it rarely occurs in unilateral diaphragmatic paralysis. 16, 17 When abdominal paradox is present in unilateral diaphragmatic paralysis, it suggests generalized weakness of the respiratory muscles. 16 
Nat ur a l His t or y
The natural history of diaphragmatic dysfunction depends largely on its cause and the rate of progression of the underlying disease. Age-related changes in respiratory drive, respiratory-muscle strength, and chest-wall compliance may predispose patients with diaphragmatic dysfunction to hypoventilation. [18] [19] [20] In certain neuromuscular diseases (e.g., muscular dystrophies), the course of diaphragmatic dysfunction is progressive, whereas in the case of post-traumatic or infectious diaphragmatic paralysis, spontaneous recovery occurs in approximately two thirds of patients but may take a considerable amount of time. 12, 13, [22] [23] [24] [25] Regeneration of the phrenic nerve, which may take up to 3 years, is necessary for recovery. 13 Patients with unilateral or bilateral diaphragmatic paralysis that is due to neuralgic amyotrophy (often marked by a history of acute shoulder or neck pain followed by dyspnea) typically have complete recovery or improvement in symptoms in 1 to 1.5 years. 13, 24 Recovery times may be somewhat shorter in patients who have diaphragmatic dysfunction after cardiac surgery. 12 In contrast, the prognosis is poor for patients who have diaphragmatic dysfunction after traumatic injury to the spinal cord. 23 
C ause s
The incidence of clinically significant diaphragmatic dysfunction is difficult to estimate, given its multiple causes. 3, 4 The causes of diaphragmatic dysfunction can be classified by the level of the impairment and are discussed here in a rostral-tocaudal sequence (Fig. 3) . With some disorders, impairment may occur at more than one anatomical level; for example, critical illness polyneuropathy may be due to both a peripheral neuropathy and myopathy. 26 The medulla or spinal cord may be affected by demyelinating plaques. However, diaphragmatic weakness is infrequently found in multiple sclerosis. 27 High spinal cord injuries (at C1 or C2) result in diaphragmatic paralysis, whereas diaphragmatic function is partially preserved with midcervical lesions (at C3 through C5). About 40% of patients with lesions at C3 require mechanical ventilation, whereas less than 15% of patients with lesions at C4 or C5 need ventilatory support. 28 Diseases involving the lower motor neurons in the spine, such as amyotrophic lateral sclerosis or poliomyelitis, often lead to diaphragmatic dysfunction and respiratory failure. Diaphragmatic weakness may occur shortly after or many years after the initial poliomyelitis infection (mean, 35 years). 29 Other diseases that cause diaphragmatic weakness and involve spinal motor neurons include syringomyelia, paraneoplastic motor neuropathies (e.g., the antiHu syndrome), and spinal muscular atrophies. Respiratory failure accounts for most of the complications and deaths caused by these disorders.
Damage to the phrenic nerve is most commonly due to iatrogenic injury during surgery or to compression caused by bronchogenic or mediastinal tumors. 30, 31 During cardiothoracic or neck surgery, damage of the phrenic nerve may be due to transection, stretching, crushing, or hypother- mia. In cardiac surgery, the use of cold saline solutions containing ice chips or slush to lower myocardial temperature is the most important risk factor for phrenic-nerve injury. 32 The avoidance of hypothermic injury to the phrenic nerve with the use of cardiac insulation pads has significantly decreased the incidence of diaphragmatic dysfunction in these patients. 33 Other processes that can directly involve the phrenic nerve include trauma, infections (e.g., herpes zoster and Lyme disease), and inflammatory disorders. The Guillain-Barré syndrome is often complicated by phrenic-nerve involvement, with up to 25% of patients requiring mechanical ventilation. 34, 35 The phrenic nerve may be involved in approximately 5% of patients with neuralgic amyotrophy (Parsonage-Turner syndrome) and in up to 2% of patients who have undergone cardiac surgery. 25, 36, 37 Disordered synaptic transmission at the neuromuscular junction may be manifested as diaphragmatic dysfunction. 3, 10, 38 In myasthenia gravis, acute respiratory failure most often occurs during myasthenic crisis, requires ventilatory support, and usually responds to immunomodulating therapy. 3 Diaphragmatic dysfunction is not commonly seen in the Lambert-Eaton syndrome. 38 Botulinum toxins (most often type A) impair diaphragmatic function by interfering with the release of acetylcholine into the neuromuscular junction. 39 In rare cases, medications, such as aminoglycosides, interfere with neuromuscular transmission, causing diaphragmatic weakness and respiratory failure. Various inherited or acquired myopathies may impair diaphragmatic function and lead to respiratory failure early in life or in adulthood. 3, 4 Critical-illness polyneuropathy and myopathy are common causes of diaphragmatic weakness and ventilator dependency in patients in the intensive care unit. 26 They are more common among patients with sepsis, multiorgan failure, and hyperglycemia and should be considered in patients for whom weaning from ventilator support is difficult. 26 Disuse atrophy of the diaphragm can occur even after brief periods of mechanical ventilation or after the administration of paralyzing agents; it is associated with atrophy of both fast-twitch and slow-twitch myofibers. [40] [41] [42] Undernutrition and metabolic abnormalities such as hypophosphatemia, hypomagnesemia, hypokalemia, hypocalcemia, and thyroid disturbances can contribute to diaphragmatic dysfunction and prolong ventilator dependency. 43, 44 The combination of diaphragmatic weakness and any process that increases the work of breathing (e.g., pneumonia, pulmonary edema, atelectasis, or bronchospasm) may overwhelm the capacity of even a mildly weakened diaphragm and contribute to prolonged mechanical ventilation. Lung hyperinflation in chronic obstructive pulmonary disease impairs diaphragmatic function by shortening the diaphragm to a suboptimal length and, to a lesser extent, by impairing mechanical advantage in the diaphragm (i.e., ineffective translation of diaphragmatic tension to transdiaphragmatic pressure). 3, 45, 46 Therapeutic interventions, such as long-acting bronchodilators, surgery to reduce lung volume, and lung transplantation, can mitigate the negative effects of hyperinflation on diaphragmatic function by promoting lung emptying and decreasing lung volume, thereby improving the length and contractility of the diaphragm. [47] [48] [49] Di agnosis
Once suspected, diaphragmatic dysfunction can be confirmed by a number of tests. Chest radiographs may reveal elevated hemidiaphragms and basal subsegmental atelectasis. 4 However, elevation of both hemidiaphragms, as is commonly seen in patients who are ventilator-dependent, may be interpreted as a "poor inspiratory effort" or "low lung volumes" and has low specificity for diagnosing diaphragmatic dysfunction. 50 Although chest radiography is a reasonably sensitive tool for detecting unilateral diaphragmatic paralysis (90%), its specificity is unacceptably low (44%). 50 Fluoroscopy of the diaphragm has been extensively used to evaluate diaphragmatic function. A "sniff test" consists of assessing the motion of the diaphragm during a short, sharp inspiratory effort through the nostrils. Descent of the diaphragm will be seen in persons without the disorder. With unilateral diaphragmatic paralysis, there is a paradoxical (cephalad) movement of the paralyzed hemidiaphragm. Although the sniff test may be used to diagnose unilateral diaphragmatic paralysis, it is no longer considered a helpful test in diagnosing bilateral diaphragmatic paralysis. 3 False positive results of the sniff test may occur in as many as 6% of patients without diaphragmatic paralysis. 51 False negative results can occur with active contraction of the abdominal muscles during expiration to volumes below functional residual capacity, followed by abrupt relaxation of the abdominal muscles at the onset of inspiration, resulting in caudal motion of the paralyzed diaphragm. This abrupt caudal motion at the onset of inspiration may be falsely interpreted as contraction of the diaphragm. 20 Decisions about workup are generally made on the basis of the invasiveness and availability of testing (Fig. 4) . Pulmonary-function tests, especially measurements of upright and supine vital capacity, are readily available, are noninvasive, and may support or refute the diagnosis of diaphragmatic dysfunction. With unilateral diaphragmatic paralysis, total lung capacity may be mildly restricted (70 to 79% of the predicted value). 10 In severe diaphragmatic weakness or bilateral diaphragmatic paralysis, there is typically moderate-to-severe restriction (30 to 50% of the predicted value for total lung capacity). In both unilateral and bilateral diaphragmatic paralysis, the restrictive dysfunction becomes more severe when the patient is in the supine position. A decrease in vital capacity of 30 to 50% when the patient is supine supports the diagnosis of bilateral diaphragmatic paralysis, whereas a decrease in vital capacity of 10 to 30% of the vital capacity when the patient is seated may be seen with mild diaphragmatic weakness or unilateral diaphragmatic paralysis. 14,21 When there is little or no reduction in supine vital capacity, the presence of clinically significant diaphragmatic weakness is unlikely. 10 The mechanism related to the reduction in supine vital capacity is the cephalad displacement of abdominal contents in concert with ineffective activity of the accessory inspiratory muscles. 14, 21 The functional residual capacity and residual volume are usually normal in patients with unilateral diaphragmatic paralysis and are decreased in those with bilateral diaphragmatic paralysis. 14, 21 Two additional measures of diaphragmatic strength are maximal static inspiratory pressure and sniff nasal inspiratory pressure. These measurements are also noninvasive but are effortdependent and more variable than measurements of lung volume. 52, 53 Maximal static inspiratory pressure and sniff nasal inspiratory pressure are mildly reduced, to about 60% of the predicted value, in patients with unilateral diaphragmatic paralysis and are markedly reduced, to less than 30% of the predicted value, in those with bilateral diaphragmatic paralysis. 14, 21 Maximal expiratory pressure is typically preserved in patients with disease processes that affect the diaphragm but spare the expiratory muscles. maximal expiratory pressure suggest that the cause of the diaphragmatic dysfunction is a generalized process involving both the inspiratory and expiratory muscles (e.g., muscular dystrophy). 21, 37 However, a mild reduction in maximal expiratory pressure (70 to 80% of the predicted value) may simply reflect suboptimal length-tension properties of the expiratory muscles at a restricted total lung capacity, rather than a generalized myopathic process. Direct measures of diaphragmatic function can be classified as invasive (e.g., transdiaphragmatic pressure [Pdi]) or noninvasive (e.g., ultrasonography). These tests may not be offered at some institutions but may be required when the diagnosis remains uncertain. Measurement of Pdi requires transnasal placement of balloon catheters in the lower esophagus and stomach (Fig. 1 in the Supplementary Appendix, available with the full text of this article at NEJM.org). Pdi is calculated as the difference between the gastric and esophageal pressures. It can be measured during tidal breathing, maximal sniff maneuvers (sniff Pdi), maximal inspiratory efforts against a closed glottis (Pdi max), or transcutaneous electrical or magnetic stimulation of the phrenic nerve (twitch Pdi). A sniff Pdi or Pdi max greater than 80 cm of water in men and greater than 70 cm of water in women rules out clinically significant diaphragmatic weakness. 52, 53 A twitch Pdi greater than 10 cm of water with unilateral phrenic-nerve stimulation or greater than 20 cm of water with bilateral phrenic-nerve stimulation also rules out clinically significant weakness. 53 Twitch Pdi is a useful means of assessing diaphragmatic function in cases in which there is an inability to perform the maneuvers required for the other Pdi tests or separate evaluation of each hemidiaphragm is necessary. 53 Although measurement of Pdi is generally considered the standard for establishing the diagnosis of bilateral diaphragmatic paralysis, 14, 20, 54 the tests are invasive and uncomfortable.
Ultrasonography of the diaphragm at its zone of apposition with the rib cage is a noninvasive technique that can be used to measure changes in the thickness of the diaphragm during inspiration ( Fig. 5; and Video 1, available at NEJM.org). Thickening of the diaphragm reflects diaphragmatic shortening, 55 and a lack of thickening with inspiration is diagnostic of diaphragmatic paralysis (Video 2). 56 Because ultrasonography can distinguish a functioning from a nonfunctioning diaphragm, it can be used to diagnose both unilateral and bilateral diaphragmatic paralysis and to monitor recovery of the paralyzed diaphragm. 24, 56 Ultrasonography of the diaphragmatic dome has also been reported as a method for documenting diaphragmatic paralysis in adults 57,58 and children 59 ; however, this technique primarily images the central tendon of the diaphragm, not the muscular component, and is subject to limitations similar to those of fluoroscopy of the diaphragm.
Electromyography of the diaphragm can be performed during quiet breathing or during stimulation of the phrenic nerve. Its role in the diagnosis of diaphragmatic paralysis or weakness is limited by a number of technical issues, including the proper placement of electrodes, the possibility of electromyographic "cross-talk" from adjacent muscles, and the variable distances between muscles and electrodes that result from differences in subcutaneous fat among patients. 11, 60 However, electromyography of the diaphragm may be useful in distinguishing between neuropathic and myopathic causes of known diaphragmatic dysfunction. 
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T r e atmen t
The treatment of patients with diaphragmatic dysfunction depends on the cause and on the presence or absence of symptoms and nocturnal hypoventilation. Examples of treatable causes of diaphragmatic dysfunction include myopathies related to metabolic disturbances such as hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia. Correction of electrolyte and hormonal imbalances and avoidance of neuropathic or neuromuscular blocking agents can restore strength in the diaphragm. Myopathies due to parasitic infection (e.g., trichinosis) may respond to appropriate antimicrobial agents. 61 Idiopathic diaphragmatic paralysis or paralysis due to neuralgic amyotrophy may improve spontaneously. 13 When diaphragmatic dysfunction persists or progresses, ventilatory support, ranging from nocturnal to continuous, may be needed. The need for ventilatory support may be temporary, as in cases of diaphragmatic paralysis after cardiac surgery, or it may be permanent, as in cases of progressive neuromuscular diseases. The generally accepted indications for initiating nocturnal noninvasive ventilation in patients with symptoms include a partial pressure of carbon dioxide of 45 mm Hg or higher in the arterial blood in the daytime, oxygen saturation of 88% or less for 5 consecutive minutes at night, or progressive neuromuscular disease with a maximal static inspiratory pressure of less than 60 cm of water or a forced vital capacity of less than 50% of the predicted value. 62 Most patients with neuromuscular disease will eventually require mechanical ventilation, whether it is provided by invasive means (tracheostomy or endotracheal tube) or noninvasive means (nasal cannula or face mask).
Plication of the diaphragm is a procedure in which the flaccid hemidiaphragm is made taut by oversewing the membranous central tendon and the muscular components of the diaphragm. The indications and timing for this procedure are not fully defined, given that most studies are retrospective and uncontrolled, but it may be offered to patients with unilateral diaphragmatic paralysis 
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who have severe dyspnea, cough, or chest pain or who are ventilator-dependent. 63 Plication of the diaphragm may result in increases of up to 20% in vital capacity, forced expiratory volume in 1 second, and total lung capacity, along with improvement in dyspnea. 63, 64 The increase in lung volumes related to plication results from immobilization of the diaphragm, which lessens its paradoxical motion. 65 In general, a long period of observation should be considered before plication is recommended. This is especially true for patients with unilateral diaphragmatic paralysis after cardiac surgery or other surgical procedures that involve the cervical or mediastinal regions, since phrenic function may improve with time. 12, 24, 66 Morbid obesity and progressive neuromuscular diseases are relative contraindications to plication of the diaphragm. 67 Plication is unlikely to be helpful in bilateral diaphragmatic paralysis. Phrenic pacing has the potential to provide full ventilatory support for ventilator-dependent patients who have bilateral diaphragmatic paralysis and intact phrenic nerves. Candidates for this method of treatment are primarily patients with high cervical cord quadriplegia or patients with central hypoventilation. Despite technical improvements in phrenic-pacing systems, activation of the diaphragm does not provide sustained, full ventilatory support. 68 Newer methods that use laparoscopic mapping of motor points and intramuscular stimulation of the diaphragm have shown promising results. 69 Sleep-disordered breathing is common among patients with diaphragmatic dysfunction, since suppression of the activity of accessory inspiratory muscles during rapid-eye-movement sleep leads to hypoventilation. 17, 70 In patients with severe diaphragmatic weakness or unilateral diaphragmatic paralysis, sleep-disordered breathing develops independently of body-mass index, sex, and age. 17 Among patients with unilateral diaphragmatic paralysis, sleep-disordered breathing is primarily found in those with clinically significant weakness (unilateral twitch Pdi, <5 cm of water). 17 Patients with diaphragmatic weakness that is due to a neuromuscular disease, such as muscular dystrophy or amyotrophic lateral sclerosis, may also have obstructive sleep apnea. Weakness of pharyngeal and laryngeal muscles may predispose these patients to airway collapse during inspiration. 70 As with other causes of sleep-disordered breathing, noninvasive positive-pressure ventilation is the preferred method of treatment for patients with diaphragmatic paralysis because it can improve both symptoms and physiological derangements. An increase in the use of ultrasonography is likely to lead to prompt identification of patients with diaphragmatic dysfunction, and further innovations in noninvasive ventilation will lead to more physiologic and comfortable ventilatory support for these persons. Advances in intramuscular pacing and treatment of congenital myopathies with enzyme-replacement or gene-transfer therapy may provide further hope for effective treatment.
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